Gilead’s twice-yearly shot to prevent HIV succeeds in late-stage trial
www.cnbc.com
Gilead's experimental twice-yearly medicine to prevent HIV was 100% effective in a late-stage trial, the company said Thursday.
  • ma11en@lemmy.world
    8·
    10 months ago

    I misread the title and thought they attempted a new medicine every 6 months!